3041 - 3050 of 9033 Results
Title
Year
-
OPENTitle: A French survey on the lockdown consequences of COVID-19 pandemic in Parkinson's disease. The ERCOPARK studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 89Issue #:Start Page: 128End Page: 133Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.07.013Best OA location URL: http://www.prd-journal.com/article/S1353802021002625/pdfCitation Count: 27
-
OPENTitle: Clinical perception and management of Parkinson's disease during the COVID-19 pandemic: A Canadian experienceJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 91Issue #:Start Page: 66End Page: 76Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.08.018Best OA location URL: http://www.prd-journal.com/article/S1353802021003126/pdfCitation Count: 18
-
OPENTitle: Frequency of mutations in PRKN, PINK1, and DJ1 in Patients With Early-Onset Parkinson Disease from neighboring countries in Central EuropeJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 86Issue #:Start Page: 48End Page: 51Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.03.026Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8192481Citation Count: 15
-
OPENTitle: Targeting transglutaminase 2 as a potential disease modifying therapeutic strategy for synucleinopathiesJournal Name: Neural Regeneration ResearchPublisher: MedknowVol: 16Issue #: 8Start Page: 1560End Page: 1560Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.4103/1673-5374.303027Best OA location URL: https://doi.org/10.4103/1673-5374.303027Citation Count: 4
-
OPENTitle: Prediction of Acute Respiratory Failure Requiring Advanced Respiratory Support in Advance of Interventions and Treatment: A Multivariable Prediction Model From Electronic Medical Record DataJournal Name: Critical Care ExplorationsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 3Issue #: 5Start Page: e0402End Page: e0402Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1097/cce.0000000000000402Best OA location URL: https://doi.org/10.1097/cce.0000000000000402Citation Count: 10
-
OPENTitle: A Blueprint for the Conduct of Large, Multisite Trials in TelemedicineJournal Name: Journal of Medical Internet ResearchPublisher: JMIR Publications Inc.Vol: 23Issue #: 9Start Page: e29511End Page: e29511Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.2196/29511Best OA location URL: https://www.jmir.org/2021/9/e29511/PDFCitation Count: 3
-
OPENTitle: Diagnostic criteria for blepharospasm: A multicenter international studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 91Issue #:Start Page: 109End Page: 114Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.09.004Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9048224Citation Count: 41
- Mural cell dysfunction leads to altered cerebrovascular tau uptake following repetitive head trauma2020OPENTitle: Mural cell dysfunction leads to altered cerebrovascular tau uptake following repetitive head traumaJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 150Issue #:Start Page: 105237End Page: 105237Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2020.105237Best OA location URL: https://www.sciencedirect.com/science/article/pii/S0969996120305131?via%3DihubCitation Count: 32
-
OPENTitle: Abrogation of LRRK2 dependent Rab10 phosphorylation with TLR4 activation and alterations in evoked cytokine release in immune cellsJournal Name: Neurochemistry InternationalPublisher: Elsevier BVVol: 147Issue #:Start Page: 105070End Page: 105070Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuint.2021.105070Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7610942Citation Count: 29
-
OPENTitle: Cerebral dopamine neurotrophic factor reduces α-synuclein aggregation and propagation and alleviates behavioral alterations in vivoJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 29Issue #: 9Start Page: 2821End Page: 2840Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ymthe.2021.04.035Best OA location URL: https://eprints.ncl.ac.uk/275504Citation Count: 45